| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |